By Topic

A new method for measuring Auto-Fluorescence changes in neovascular-AMD after intravitreal injection of Bavecizumab

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

3 Author(s)
Mohammad Norouzifard ; Islamic Azad University Science and Research Branch, Tehran, I.R.Iran ; Ali Soleymani ; Jamshid Shanbehzadeh

Age-related macular degeneration (AMD) is the second disease diabetes which causes blindness in aged people. The only remedy for AMD is intravenous injection of Bavecizumab. To prove the efficiency of remedy, the degenerated cells in macula should be measured. In this paper, the new software is introduced to measure auto-fluorescence in macula part of retina in order to determine the number of degenerated cells. This system is consists of three main parts: low level pre-processing, image analysis and images understanding. Experiments have been done on a database of 34 retina images of before and after AMD patients remedy. The average number of decreased degenerated cells after remedy was 15134. In clinical reviews, the founded relation to disinflation of macula has been proved, while there were no proved relations to the vision decreasing or increasing of patients.

Published in:

2009 International Conference on the Current Trends in Information Technology (CTIT)

Date of Conference:

15-16 Dec. 2009